STAR

Strides Pharma : Co. Receives USFDA EIR Closure for US Facility • 🇺🇸 Regulatory Clearance: USFDA issues Inspection Closure Report (EIR) for Chestnut Ridge, New York formulations facility. • ✅ VAI Classification: Inspection concluded with Voluntary Action Indicated (VAI); no critical observations pending. • 💊 Nasal Spray Filing Covered: Inspection included Drug–Device Combinations, supporting recent nasal spray filings. • 📈 US Business Boost: Facility supplies multiple dosage forms for the US market, aiding near-term launches. 🟢 Impact: Positive Regulatory overhang removed, strengthens US pipeline visibility, and supports growth from complex products including nasal sprays.